Health and Medicine (Audio)

In this Front Row presentation, Kristian Andersen shares how he, with a global network of collaborators, applies a ‘team science’ approach to deciphering outbreaks of emerging diseases such as Ebola and Lassa Virus. His highly cross-disciplinary work combines next-generation sequencing, computational biology, experimentation and field work to investigate how viruses emerge and cause large-scale outbreaks. Series: "Front Row at Scripps Research" [Show ID: 34808]

Worldwide 50 million people live with dementia. By 2040 over 70% of them will be living in the developing world. Dr. Shamiel McFarlane explores the social and economic cost of dementia around the world. Series: "Mini Medical School for the Public" [Health and Medicine] [Show ID: 34779]

The Drug Policy Alliance advances policies and attitudes that best reduce the harms of both drug use and drug prohibition, and promotes the sovereignty of individuals over their minds and bodies. California's deputy director Laura Thomas talks about the history of drug prohibition, the consequences and a more effective path moving forward. Series: "Mini Medical School for the Public" [Health and Medicine] [Show ID: 34792]

Dr. Dan Lowenstein is UCSF's Vice Chancellor and Provost. In this interview, he describes his circuitous path to a career in medicine, his passion for social justice, and the importance of authenticity for leaders. Lowenstein is an accomplished physician-scientist in the area of epilepsy, an award-winning medical educator, and an innovative and forward-thinking leader. In prior roles, he helped launch UCSF's Academy of Medical Educators, led UCSF's Physician-Scientist training programs, and served as Dean for Education of Harvard Medical School. As UCSF's provost, he oversees the university's academic programs and is taking a leading role in issues ranging from the modernization of the Parnassus Heights campus to the future of big data in healthcare. Series: "A Life in Medicine: People Shaping Healthcare Today" [Show ID: 35135]

There are modifiable behaviors that may reduce the risk factor of Alzheimer's: vascular disease, sedentary lifestyle, depression/stress, diet factors and alcohol. Kaitlin Casaletto talks about the benefits of an active lifestyle and proper nutrition. Then Dr. Joanna Hellmuth looks at how to decode direct-to-consumer interventions - dietary supplements - and the rise of pseudo-medicine for dementia. She explains that supplements may or may not be safe and that manufacturers can make broad claims without supporting evidence. Series: "Mini Medical School for the Public" [Show ID: 35136]

A team of engineers at UC Berkeley and the Keck Graduate Institute (KGI) of The Claremont Colleges combined CRISPR with electronic transistors made from graphene to create a new hand-held device that can detect specific genetic mutations in a matter of minutes. The device, dubbed CRISPR-Chip, could be used to rapidly diagnose genetic diseases or to evaluate the accuracy of gene-editing techniques. The team used the device to identify genetic mutations in DNA samples from Duchenne muscular dystrophy patients. Series: "UC Berkeley News" [Show ID: 35130]

Deaths from drug overdose are greater than from car accidents or guns. Dr. Daniel Ciccarone, talks about the triple wave: opioids, heroin and fentanyl. This epidemic is the worst in decades and a comprehensive response is needed. Series: "Mini Medical School for the Public" [Health and Medicine] [Show ID: 34791]

Dr. Julio Rojas-Martinez discusses the pharmacological treatment of Alzheimer’s disease now and what is in development. Current approaches pursue early intervention in the dementia phase. Novel emerging strategies will likely accompany anti-amyloid and anti-tau approaches in the future. Then Sarah Dulaney, RN, describe dementia education, support, and non-pharmacological treatment strategies. Series: "Mini Medical School for the Public" [Health and Medicine] [Show ID: 34777]

Garrett Roll, MD, Assistant Professor of Surgery, Connie Frank Transplant Center UCSF, and Sindhu Chandran, MD, Associate Professor of Medicine, Connie Frank Transplant Center, UCSF. Series: "UCSF Transplant Update" [Health and Medicine] [Education] [Professional Medical Education] [Show ID: 35054]

Dr. Phillip Coffin talks about the history of opioid crisis and available medical treatments. Coffin is the director of substance use research at the San Francisco Department of Public Health and assistant professor in the division of HIV/AIDS at the University of California, San Francisco Series: "Mini Medical School for the Public" [Health and Medicine] [Show ID: 34790]

Dr. Grace Dammann, medical director of the Pain Clinic at Laguna Honda Hospital, and seven of her colleagues talk about what does and does not work in the treatment of chronic pain. She talks as both a patient and a provider. There is also a discussion of various non-pharmacologic and complementary medicine modalities to treat pain. Series: "Mini Medical School for the Public" [Health and Medicine] [Show ID: 34789]

Elaine Ku, MD, Assistant Professor of Medicine and Pediatrics, Connie Frank Transplant Center, UCSF. Series: "UCSF Transplant Update" [Health and Medicine] [Education] [Professional Medical Education] [Show ID: 35050]

Flavio Vincenti, MD, Professor of Surgery, Connie Frank Transplant Center, UCSF. Series: "UCSF Transplant Update" [Health and Medicine] [Education] [Professional Medical Education] [Show ID: 35052]

Insulin is necessary to utilize the energy we obtain from carbohydrates. Diabetes is characterized by a relative or absolute lack of insulin production. Dr. Sarah Kim explores the way the body digests carbohydrates and its effect on the pancreas and blood sugar levels. Series: "Mini Medical School for the Public" [Health and Medicine] [Show ID: 35069]

Jun Shoji, MD, Assistant Professor of Medicine, Connie Frank Transplant Center, UCSF. Series: "UCSF Transplant Update" [Health and Medicine] [Education] [Professional Medical Education] [Show ID: 35053]